159 related articles for article (PubMed ID: 81059)
1. Inhibition of cyclic AMP phosphodiesterase by 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-[2-(N-benzyl-N-methylamino)] ethyl ester 5-methyl ester hydrochloride (YC-93), a potent vasodilator.
Sakamoto N; Terai M; Takenaka T; Maeno H
Biochem Pharmacol; 1978; 27(8):1269-74. PubMed ID: 81059
[No Abstract] [Full Text] [Related]
2. Vasodilator profile of a new 1,4-dihydropyridine derivative, 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-[2-(N-benzyl-N-methylamino)]-ethyl ester 5-methyl ester hydrochloride (YC-93).
Takenaka T; Usuda S; Nomura T; Maeno H; Sado T
Arzneimittelforschung; 1976; 26(12):2172-8. PubMed ID: 1037267
[TBL] [Abstract][Full Text] [Related]
3. Dissociation of cyclic AMP and contractile responses to isoprenaline: effects of a dihydropyridine derivative, nicardipine (YC-93), on canine ventricular muscle.
Endoh M; Yanagisawa T; Taira N
Eur J Pharmacol; 1980 Oct; 67(2-3):225-33. PubMed ID: 6257529
[TBL] [Abstract][Full Text] [Related]
4. Dihydro- and tetrahydroisoquinolines as inhibitors of cyclic nucleotide phosphodiesterases from dog heart. Structure-activity relationships.
Van Inwegen RG; Salaman P; St Georgiev V; Weinryb I
Biochem Pharmacol; 1979 Apr; 28(8):1307-12. PubMed ID: 87199
[No Abstract] [Full Text] [Related]
5. Trapidil derivatives as potent inhibitors of cyclic AMP phosphodiesterase from heart and coronary arteries.
Bartel S; Tenor H; Krause EG
Biomed Biochim Acta; 1985; 44(5):K31-5. PubMed ID: 2415118
[TBL] [Abstract][Full Text] [Related]
6. Selective inhibition of cyclic AMP and cyclic GMP phosphodiesterases of cardiac nuclear fraction.
Ahluwalia GS; Rhoads AR
Biochem Pharmacol; 1982 Mar; 31(5):665-9. PubMed ID: 6177320
[TBL] [Abstract][Full Text] [Related]
7. Determination of a new cerebral vasodilator 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-[2-(N-benzyl-N-methylamino)]-ethyl ester 5-methyl ester hydrochloride (YC-93) in plasma by electron capture gas chromatography.
Higuchi S; Sasaki H; Sado T
J Chromatogr; 1975 Jul; 110(2):301-7. PubMed ID: 1150838
[TBL] [Abstract][Full Text] [Related]
8. Methylxanthine inhibitors of phosphodiesterases.
Wells JN; Miller JR
Methods Enzymol; 1988; 159():489-96. PubMed ID: 2457788
[No Abstract] [Full Text] [Related]
9. Effects of 2-nicotinamidethyl nitrate (SG-75), a new antianginal drug, on the cyclic AMP phosphodiesterase activity.
Endoh M; Yanagisawa T; Taira N
Tohoku J Exp Med; 1980 Feb; 130(2):199-201. PubMed ID: 6247783
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of 3',5'-cyclic nucleotide 3'-phosphohydrolase by a novel 1',2'-cyclic nucleotide.
Nair V; Wiechert RJ; Young DA
J Cyclic Nucleotide Res; 1982; 8(3):181-90. PubMed ID: 6187785
[No Abstract] [Full Text] [Related]
11. Studies on the possible role of cyclic AMP in drug-induced coronary vasodilatation.
Pöch G; Kukovetz WR
Adv Cyclic Nucleotide Res; 1972; 1():195-211. PubMed ID: 4353168
[No Abstract] [Full Text] [Related]
12. Inhibitory effect of NZ-105, a 1,4-dihydropyridine derivative, on cyclic nucleotide phosphodiesterase activity.
Yamashita T; Masuda Y; Sakai T; Tanaka S; Kasuya Y
J Pharm Pharmacol; 1993 Jun; 45(6):530-4. PubMed ID: 7689649
[TBL] [Abstract][Full Text] [Related]
13. The role of cyclic AMP and phosphodiesterase activity in the mechanism of action of tetramethylpyrazine on human and dog cardiac and dog coronary arterial tissues.
Lin CI; Wu SL; Tao PL; Chen HM; Wei J
J Pharm Pharmacol; 1993 Nov; 45(11):963-6. PubMed ID: 7908037
[TBL] [Abstract][Full Text] [Related]
14. Griseolic acid, a cAMP phosphodiesterase inhibitor, and its ester: increase in cellular cAMP levels and reduction of intraocular pressure.
Yamazaki M; Yasumoto T; Iijima Y; Yokoyama T; Fukami S; Kaneko M; Kiuchi Y; Mishima H
Adv Second Messenger Phosphoprotein Res; 1990; 24():502-6. PubMed ID: 1698412
[No Abstract] [Full Text] [Related]
15. Actions of papaverine on intestinal smooth muscle and its inhibition of cyclic AMP and cyclic GMP phosphodiesterases.
Miyamoto M; Takayanagi I; Ohkubo H; Takagi K
Jpn J Pharmacol; 1976 Feb; (1):114-7. PubMed ID: 177797
[No Abstract] [Full Text] [Related]
16. Inhibition of cyclic AMP phosphodiesterase activity and myocardial contractility: effects of cilostamide, a novel PDE inhibitor, and methylsiobutylxanthine on rabbit and canine ventricular muscle.
Endoh M; Satoh K; Yamashita S
Eur J Pharmacol; 1980 Aug; 66(1):43-52. PubMed ID: 6157546
[No Abstract] [Full Text] [Related]
17. Irreversible inhibition of calmodulin-sensitive cyclic nucleotide phosphodiesterase.
Sullivan TA; Duemler BH; Kuttesch NJ; Keravis TM; Wells JN
J Cyclic Nucleotide Protein Phosphor Res; 1986; 11(5):355-64. PubMed ID: 2442214
[TBL] [Abstract][Full Text] [Related]
18. [Inhibition of platelet aggregation and cyclic nucleotide phosphodiesterase (specifically cyclAMP) by 3-hydroxypyridine derivatives].
Kagan VE; Polianskiĭ NB; Muranov KO; Shvedova AA; Smirnov LD
Biull Eksp Biol Med; 1984 Apr; 97(4):416-8. PubMed ID: 6202339
[TBL] [Abstract][Full Text] [Related]
19. [Inhibition of cyclic nucleotide phosphodiesterase from rabbit heart by hydroxypyridines].
Polyansky NB; Smirnov LD; Shvedova AA; Kagan VE; Tkachuk VA
Vopr Med Khim; 1983; 29(1):123-7. PubMed ID: 6301154
[TBL] [Abstract][Full Text] [Related]
20. Silymarin: potent inhibitor of cyclic AMP phosphodiesterase.
Koch HP; Bachner J; Löffler E
Methods Find Exp Clin Pharmacol; 1985 Aug; 7(8):409-13. PubMed ID: 3001454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
